CHICO, Calif. – "What we found was really dramatic," said Chief Medical Officer at Enloe Medical Center, Dr. Marcia Nelson.
Nelson said they have been using monoclonal antibodies since mid-December to treat mild to moderate COVID-19 infections.
"We started doing it when we found out it was a good way to get people better faster," she said. "We have been doing internal projections in the hospital for what to expect with COVID-19 since last June."
Those projections show that with the Thanksgiving holiday there was a 233% increase in cases in Butte County.
"So, we expected a similar cases increase at Enloe in January, but they went down," said Dr. Nelson.
"We believe that with our data it was monoclinic antibodies."
Over 200 monoclonal infusions have been administered at Enloe as of Feb. 18, 2021. Dr. Nelson explained that the IV infusion treatment attacks the “spike proteins” on the Coronavirus that attach to human cells.
"The important thing for people is to know that it is available, so they know that they can ask for it."
Dr. Nelson said that for right now monoclonal antibodies treatment is only available for those who have had the infectious disease COVID-19. She added, if someone receives the treatment, they can still get a vaccine, but that they would need to wait at least a few weeks in between.
Those who qualify for the treatment can visit their primary care physician and try to get a referral to Enloe.